292 related articles for article (PubMed ID: 17272674)
21. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
22. Repurposing Resveratrol and Fluconazole To Modulate Human Cytochrome P450-Mediated Arachidonic Acid Metabolism.
El-Sherbeni AA; El-Kadi AO
Mol Pharm; 2016 Apr; 13(4):1278-88. PubMed ID: 26918316
[TBL] [Abstract][Full Text] [Related]
23. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
24. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
25. Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20-hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole.
Diani-Moore S; Papachristou F; Labitzke E; Rifkind AB
Drug Metab Dispos; 2006 Aug; 34(8):1376-85. PubMed ID: 16714371
[TBL] [Abstract][Full Text] [Related]
26. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
27. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
Knickle LC; Bend JR
Mol Pharmacol; 1994 Jun; 45(6):1273-80. PubMed ID: 8022420
[TBL] [Abstract][Full Text] [Related]
28. 14,15-epoxyeicosatrienoic acid produced by cytochrome P450s enhances neurite outgrowth of PC12 and rat hippocampal neuronal cells.
Oguro A; Inoue T; Kudoh SN; Imaoka S
Pharmacol Res Perspect; 2018 Oct; 6(5):e00428. PubMed ID: 30237892
[TBL] [Abstract][Full Text] [Related]
29. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
30. Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein.
Widstrom RL; Norris AW; Spector AA
Biochemistry; 2001 Jan; 40(4):1070-6. PubMed ID: 11170430
[TBL] [Abstract][Full Text] [Related]
31. Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2.
Arnold WR; Weigle AT; Das A
J Inorg Biochem; 2018 Jul; 184():88-99. PubMed ID: 29689453
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450-dependent arachidonic acid metabolism in human kidney.
Schwartzman ML; Martasek P; Rios AR; Levere RD; Solangi K; Goodman AI; Abraham NG
Kidney Int; 1990 Jan; 37(1):94-9. PubMed ID: 2105407
[TBL] [Abstract][Full Text] [Related]
33. The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism.
Bornheim LM; Kim KY; Chen B; Correia MA
Biochem Biophys Res Commun; 1993 Dec; 197(2):740-6. PubMed ID: 8267610
[TBL] [Abstract][Full Text] [Related]
34. Identification of rabbit cytochromes P450 2C1 and 2C2 as arachidonic acid epoxygenases.
Laethem RM; Koop DR
Mol Pharmacol; 1992 Dec; 42(6):958-63. PubMed ID: 1480136
[TBL] [Abstract][Full Text] [Related]
35. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
Imig JD
Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
[TBL] [Abstract][Full Text] [Related]
36. Influence of a fibric acid type of hypolipidemic agent on the oxidative metabolism of arachidonic acid by liver microsomal cytochrome P-450.
Capdevila J; Kim YR; Martin-Wixtrom C; Falck JR; Manna S; Estabrook RW
Arch Biochem Biophys; 1985 Nov; 243(1):8-19. PubMed ID: 3933431
[TBL] [Abstract][Full Text] [Related]
37. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
Althurwi HN; Elshenawy OH; El-Kadi AO
J Cardiovasc Pharmacol; 2014 Feb; 63(2):167-77. PubMed ID: 24157956
[TBL] [Abstract][Full Text] [Related]
38. Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells.
Revtyak GE; Hughes MJ; Johnson AR; Campbell WB
Am J Physiol; 1988 Aug; 255(2 Pt 1):C214-25. PubMed ID: 3407766
[TBL] [Abstract][Full Text] [Related]
39. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol.
Althurwi HN; Maayah ZH; Elshenawy OH; El-Kadi AO
Drug Metab Dispos; 2015 Aug; 43(8):1254-66. PubMed ID: 26033621
[TBL] [Abstract][Full Text] [Related]
40. Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.
Minuz P; Jiang H; Fava C; Turolo L; Tacconelli S; Ricci M; Patrignani P; Morganti A; Lechi A; McGiff JC
Hypertension; 2008 May; 51(5):1379-85. PubMed ID: 18378855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
